Suchergebnisse - "Catechol O-Methyltransferase Inhibitors"

PubPharm (1.110)

41

Effects of One-Day Application of Levodopa/Carbidopa/Entacapone versus Levodopa/Carbidopa/Opicapone in Parkinson's Disease Patients

enthalten in: Cells | 2022

von Müller, T. | Schlegel, E. | Zingler, S. | +1

42

1-Hydroxy-2(1H)-pyridinone-Based Chelators with Potential Catechol O-Methyl Transferase Inhibition and Neurorescue Dual Action against Parkinson's Disease

enthalten in: Molecules (Basel, Switzerland) | 2022

von Bergin, J. | Tan, K. | Nelson, A. | +7

43

Opicapone in UK clinical practice : effectiveness, safety and cost analysis in patients with Parkinson's disease

enthalten in: Neurodegenerative disease management | 2022

von Schofield, C. | Chaudhuri, K. | Carroll, C. | +8

44

Label-free LC-HRMS-based enzymatic activity assay for the detection of DDC, MAO and COMT inhibitors

enthalten in: Journal of pharmaceutical and biomedical analysis | 2022

von Harfouche, A. | Alata, W. | Leblanc, K. | +3

45

COMT Inhibitors in the Management of Parkinson's Disease

enthalten in: CNS drugs | 2022

von Fabbri, M. | Ferreira, J. | Rascol, O.

46

Comparative examination of levodopa pharmacokinetics during simultaneous administration with lactoferrin in healthy subjects and the relationship between lipids and COMT inhibitory activity in vitro

enthalten in: Nutritional neuroscience | 2022

von Nagai, M. | Kubo, M. | Ando, R. | +4

47

Opicapone for the Treatment of Parkinson's Disease "Off" Episodes : Pharmacology and Clinical Considerations

enthalten in: Clinical drug investigation | 2022

von Berger, A. | Robinson, C. | Winnick, A. | +10

48

Metabolism and disposition of opicapone in the rat and metabolic enzymes phenotyping

enthalten in: Pharmacology research & perspectives | 2022

von Loureiro, A. | Fernandes-Lopes, C. | Bonifácio, M. | +3

49

Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy : The PD MED Randomized Clinical Trial

enthalten in: JAMA neurology | 2022

von Gray, R. | Patel, S. | Ives, N. | +110

CommentIn: JAMA Neurol. 2022 Feb 1;79(2):119-120. - PMID 34962569

50

Efficacy and Safety of Opicapone for Motor Fluctuations as an Adjuvant to Levodopa Therapy in Patients with Parkinson's Disease : A Systematic Review and Meta-Analysis

enthalten in: Journal of Parkinson's disease | 2022

von Kwak, N. | Park, J. | Kang, H. | +3